Faculty, Staff and Student Publications
Language
English
Publication Date
3-24-2026
Journal
Blood Advances
DOI
10.1182/bloodadvances.2025016780
PMID
41558030
Abstract
Lower gastrointestinal graft-versus-host disease (LGI-GVHD) carries morbidity and mortality for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), with critical contributions from the intestinal microbiome. In a retrospective cohort of metagenomic sequencing of stool from patients with allo-HSCT (N = 90), we found that a reduction in specific Parabacteroides and Bacteroides species around the time of engraftment contributes to LGI-GVHD risk. Given the known diverse carbohydrate-degrading functionality of these bacteria, we investigated gene abundances for carbohydrate-active enzymes (CAZymes) and found that Parabacteroides merdae, P distasonis, and Bacteroides ovatus abundances were significantly correlated with CAZymes in patients who did not develop LGI-GVHD compared with those who did. The specific gene abundances of xylosidase, which contribute to the degradation of xylose-containing polysaccharides, were significantly associated with a reduced risk of LGI-GVHD. All these findings show the importance of the carbohydrate-degrading functionality of putative beneficial bacteria in mediating risk of LGI-GVHD.
Keywords
Humans, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Gastrointestinal Microbiome, Feces, Female, Male, Incidence, Middle Aged, Bacteria, Adult, Carbohydrate Metabolism, Retrospective Studies, Gastrointestinal Diseases, Metagenomics
Published Open-Access
yes
Recommended Citation
Fan, Christopher; Hayase, Tomo; Chang, Chia-Chi; et al., "Fecal Carbohydrate-Degrading Bacteria Are Associated With Reduced Incidence of Lower Gastrointestinal GVHD" (2026). Faculty, Staff and Student Publications. 6287.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6287
Graphical Abstract
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons